Table 1.
Per allele change in body fat % βa |
Stage 1 | Stage 2 | Stage 1+2 | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Locus | Meta-analysis | Frequency effect allele |
Explained variance (%) |
N | P | N | P | N | P | |
rs2943650 (near IRS1) Chr2: 226,814,165 bp Effect allele: T |
All individuals | 64 | −0.16 | 0.03 | 36,574 | 7.9×10−9 | 39,576 | 1.9×10−4 | 76,150 | 3.8×10−11 |
Europeans | 64 | −0.16 | 0.03 | 29,017 | 3.1×10−6 | 39,576 | 1.9×10−4 | 68,593 | 6.0×10−9 | |
Indian-Asians | 69 | NA | NA | 7,557 | 2.7×10−4 | NA | NA | NA | NA | |
Men | 64 | −0.20 | 0.06 | 19,751 | 4.1×10−8 | 24,047 | 3.4×10−5 | 43,798 | 2.9×10−11 | |
European men | 63 | −0.20 | 0.06 | 13,216 | 4.1×10−6 | 24,047 | 3.4×10−5 | 37,263 | 1.8×10−9 | |
Women | 64 | −0.06 | 0.00 | 16,823 | 0.0027 | 15,529 | 0.47 | 32,352 | 9.0×10−3 | |
European women | 63 | −0.06 | 0.00 | 15,801 | 0.012 | 15,529 | 0.47 | 31,330 | 0.024 | |
rs534870 (nearSPRY2) Chr13: 79,857,208 bp Effect allele: A |
All individuals | 68 | −0.14 | 0.02 | 36,488 | 3.2×10−6 | 34,342 | 2.6×10−3 | 70,831 | 6.5×10−8 |
Europeans | 70 | −0.14 | 0.02 | 28,931 | 7.9×10−7 | 34,342 | 2.6×10−3 | 63,273 | 3.2×10−8 | |
Indian-Asians | 68 | NA | NA | 7,557 | 0.52 | NA | NA | NA | NA | |
Men | 68 | −0.18 | 0.04 | 19,726 | 0.0016 | 20,537 | 2.1×10−3 | 40,263 | 1.1×10−5 | |
European men | 69 | −0.18 | 0.04 | 13,190 | 8.6×10−5 | 20,537 | 2.1×10−3 | 33,727 | 1.6×10−6 | |
Women | 69 | −0.06 | 0.01 | 16,763 | 9.0×10−4 | 13,805 | 0.34 | 30,568 | 2.2×10−3 | |
European women | 69 | −0.06 | 0.01 | 15,741 | 0.0027 | 13,805 | 0.34 | 29,546 | 0.0048 | |
rs8050136 (FTO) Chr16: 52,373,776 bp Effect allele: C |
All individuals | 60 | −0.33 | 0.11 | 36,537 | 3.9×10−17 | 34,105 | 4.4×10−11 | 70,642 | 2.7×10−26 |
Europeans | 59 | −0.33 | 0.11 | 28,980 | 4.6×10−16 | 34,105 | 4.4×10−11 | 63,085 | 5.6×10−25 | |
Indian-Asians | 68 | NA | NA | 7,557 | 0.011 | NA | NA | NA | NA | |
Men | 60 | −0.29 | 0.10 | 19,739 | 2.5×10−8 | 20,624 | 6.0×10−7 | 40,363 | 1.3×10−13 | |
European men | 59 | −0.29 | 0.10 | 13,204 | 2.1×10−7 | 20,624 | 6.0×10−7 | 33,828 | 1.7×10−12 | |
Women | 60 | −0.39 | 0.13 | 16,798 | 1.2×10−8 | 13,481 | 1.6×10−5 | 30,279 | 1.1×10−12 | |
European women | 59 | −0.39 | 0.13 | 15,776 | 2.2×10−8 | 13,481 | 1.6×10−5 | 29,257 | 2.7×10−12 |
The effect allele for each locus is the body fat percentage decreasing (major) allele. Chromosomal positions are indicated according to Build 36 and allele coding based on the positive strand.
bp, base pairs; Chr, chromosome; NA, no individuals available for analysis.
Effect sizes in % obtained from stage 2 studies only which included only individuals of white European descent.